Published in Biochem Biophys Res Commun on June 16, 2009
Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide. J Neuroinflammation (2010) 0.85
Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes. PLoS One (2012) 0.84
The kallikrein-kinin system as a regulator of cardiovascular and renal function. Compr Physiol (2011) 0.81
Analysis of the gene expression profile of curcumin-treated kidney on endotoxin-induced renal inflammation. Inflammation (2013) 0.78
Effect of prophylactic supplementation with grape polyphenolics on endotoxin-induced serum secretory phospholipase A2 activity in rats. Comp Med (2012) 0.77
Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additive. Front Pharmacol (2015) 0.76
Chemical Profiles and Protective Effect of Hedyotis diffusa Willd in Lipopolysaccharide-Induced Renal Inflammation Mice. Int J Mol Sci (2015) 0.75
The Tm7sf2 Gene Deficiency Protects Mice against Endotoxin-Induced Acute Kidney Injury. PLoS One (2015) 0.75
Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res (2008) 2.12
Urine in clinical proteomics. Mol Cell Proteomics (2008) 2.05
Obstructive nephropathy: insights from genetically engineered animals. Kidney Int (2005) 1.97
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl (2008) 1.57
Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol (2007) 1.56
Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med (2006) 1.52
Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res (2007) 1.52
LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol (2007) 1.51
Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol (2010) 1.48
Proteome-based systems biology analysis of the diabetic mouse aorta reveals major changes in fatty acid biosynthesis as potential hallmark in diabetes mellitus-associated vascular disease. Circ Cardiovasc Genet (2014) 1.44
YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcylation). J Biol Chem (2003) 1.25
Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev (2009) 1.19
Addressing the challenge of defining valid proteomic biomarkers and classifiers. BMC Bioinformatics (2010) 1.16
Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. J Biol Chem (2011) 1.14
Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids. BMC Genomics (2008) 1.13
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin Appl (2010) 1.12
The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics (2009) 1.11
Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors. Int J Oncol (2006) 1.11
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion. Cell Cycle (2013) 1.08
Lysophosphatidic acid and renal fibrosis. Biochim Biophys Acta (2008) 1.04
CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clin Appl (2010) 1.02
Molecular mechanisms of sorafenib action in liver cancer cells. Cell Cycle (2012) 1.01
The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy. Proteomics Clin Appl (2008) 1.01
In vivo bradykinin B2 receptor activation reduces renal fibrosis. J Clin Invest (2002) 1.01
Implementation of proteomic biomarkers: making it work. Eur J Clin Invest (2012) 1.00
Congenital ureteropelvic junction obstruction: human disease and animal models. Int J Exp Pathol (2010) 0.99
Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy. Int J Oncol (2006) 0.99
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation. Oncotarget (2014) 0.98
Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes (2008) 0.96
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle (2010) 0.95
Lysophosphatidic acid-1-receptor targeting agents for fibrosis. Expert Opin Investig Drugs (2011) 0.94
Blockade of the kinin B1 receptor ameloriates glomerulonephritis. J Am Soc Nephrol (2010) 0.91
Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment. Circulation (2002) 0.90
Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas. Mod Pathol (2008) 0.90
Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice. PLoS One (2013) 0.90
A novel protein-protein interaction between a G protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation. J Biol Chem (2002) 0.90
Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients. Can J Physiol Pharmacol (2002) 0.90
Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy. Contrib Nephrol (2008) 0.90
Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can J Physiol Pharmacol (2002) 0.89
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer. Mol Oncol (2011) 0.89
Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression. Gynecol Oncol (2012) 0.89
Clinical proteomics in obstetrics and neonatology. Expert Rev Proteomics (2014) 0.88
Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application. Adv Chronic Kidney Dis (2010) 0.88
Non-invasive markers of ureteropelvic junction obstruction. World J Urol (2007) 0.88
Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV). Sci Transl Med (2013) 0.87
Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatr Nephrol (2009) 0.87
The KUPKB: a novel Web application to access multiomics data on kidney disease. FASEB J (2012) 0.87
Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments. Anal Bioanal Chem (2008) 0.87
Role of malignant ascites on human mesothelial cells and their gene expression profiles. BMC Cancer (2014) 0.87
Genes invoked in the ovarian transition to menopause. Nucleic Acids Res (2006) 0.86
Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function. Biol Chem (2006) 0.86
Systems biology: opening new avenues in clinical research. Nephrol Dial Transplant (2010) 0.84
Renal fibrosis: insight from proteomics in animal models and human disease. Proteomics (2011) 0.84
Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma. PLoS One (2011) 0.84
Urinary Peptide Analysis Differentiates Pancreatic Cancer From Chronic Pancreatitis. Pancreas (2016) 0.84
Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis. Exp Biol Med (Maywood) (2009) 0.84
Renal tubular fluid shear stress facilitates monocyte activation toward inflammatory macrophages. Am J Physiol Renal Physiol (2012) 0.84
Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney. Physiol Genomics (2013) 0.83
Renal tubular fluid shear stress promotes endothelial cell activation. Biochem Biophys Res Commun (2011) 0.83
COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells. OMICS (2011) 0.82
Inhibition of IGF-I-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin. Kidney Int (2002) 0.82
Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine. Mod Pathol (2013) 0.82
Bradykinin and renal fibrosis: have we ACE'd it? J Am Soc Nephrol (2004) 0.81
Functional rescue of a defective angiotensin II AT1 receptor mutant by the Mas protooncogene. Regul Pept (2007) 0.81
Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells. PLoS One (2013) 0.81
[Bradykinin receptors: towards new pathophysiological roles]. Med Sci (Paris) (2003) 0.81
Human epididymis protein 4 (HE4) and ovarian cancer prognosis. Gynecol Oncol (2012) 0.81
Specimen quality evaluation in Canadian biobanks participating in the COEUR repository. Biopreserv Biobank (2013) 0.81
The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures. Int J Biochem Cell Biol (2008) 0.81
Participation of transmembrane proline 82 in angiotensin II AT1 receptor signal transduction. Regul Pept (2007) 0.80
miRNAs in urine: a mirror image of kidney disease? Expert Rev Mol Diagn (2015) 0.80
Hnf-1β transcription factor is an early hif-1α-independent marker of epithelial hypoxia and controls renal repair. PLoS One (2013) 0.80
Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. PLoS One (2013) 0.79
The protective effect of angiotensin converting enzyme inhibition in experimental renal fibrosis in mice is not mediated by bradykinin B2 receptor activation. Thromb Haemost (2003) 0.79
A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer. Gynecol Oncol (2013) 0.79
Renal gene expression profiling using kinin B1 and B2 receptor knockout mice reveals comparable modulation of functionally related genes. Biol Chem (2006) 0.79
Renal and urinary proteomics. Proteomics Clin Appl (2011) 0.78
Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors. BMC Cancer (2008) 0.78
A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation. Gynecol Oncol (2012) 0.78
Systems biology to battle vascular disease. Nephrol Dial Transplant (2010) 0.78